CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on …
Comments Off on CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on …
June 1, 2026
✦ New CED Clinical Relevance #61 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CancerResearchCBDAgingCannabinoid ScienceOncologyEpigenetics Clinical Summary CBIH has completed a patent application…
Can Epigenetic Therapies Break the Vicious Cycle Between Gum Disease and Diabetes?
Comments Off on Can Epigenetic Therapies Break the Vicious Cycle Between Gum Disease and Diabetes?
April 30, 2026
Periodontitis diabetes epigenetics reveal shared molecular pathways worsening both diseases. This 2025 narrative review explores CBD and metformin as potential epigenetic modulators. Evidence remains preclinical with no clinical trial support yet.
Medicinal Cannabis Extract NTI164 Modulates Pediatric Neuropsychiatric Pathways
Comments Off on Medicinal Cannabis Extract NTI164 Modulates Pediatric Neuropsychiatric Pathways
March 26, 2026
Pediatric cannabis neuropsychiatric research reveals NTI164, a low-THC cannabis extract, modifies epigenetic, ribosomal, and immune pathways in PANS. This study provides early molecular insights into cannabis effects on pediatric neuropsychiatric…